Xellera Therapeutics provides end-to-end cell and gene therapy solutions, from early process development to cGMP-compliant manufacturing. With proven expertise in CAR-T, iPSC, and MSC technologies, we enable the delivery of safe, high-quality therapies designed to meet clinical needs and international regulatory standards. https://xelleratherapeutics.blogspot.com/2025/06/impact-of-cell-and-gene-therapy.html